首页 › 基金 › ADAR1 Capital Management, LLC › IKT

ADAR1 Capital Management, LLC 对 IKT 的持仓历史

INHIBIKASE THERAPEUTICS INC · 医疗保健

ADAR1 Capital Management, LLC 在 Q3 2026 的 13F 申报中披露持有 IKT(INHIBIKASE THERAPEUTICS INC)5,708,755 股,市值约 US$11.7M,约占其申报组合的 0.64%,在其申报持仓中市值排名第 42 位。 ADAR1 Capital Management, LLC 最近 8 个申报季度中有 8 个季度披露了 IKT 持仓,最早可追溯至 Q4 2024。

最新持仓 (Q3 2026)5.71M 股
申报持仓市值$11.73M
组合权重0.64%
首次申报Q4 2024
最近变动减持
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

ADAR1 Capital Management, LLC 对 IKT 的持仓演变

ADAR1 Capital Management, LLC 于 Q4 2024 首次披露 IKT 持仓:5,103,005 股(约 US$16.6M)。 在 8 次申报中,ADAR1 Capital Management, LLC 3 次增持、2 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 5,708,755 股、市值约 US$11.7M,环比减持 -1,678,450 股。。 持仓曾出现大幅变动:Q4 2025 增持约 54% (随后一个季度股价下跌 18%)。

逐季持仓明细

季度股数金额变化
Q4 2024 5.10M $16.58M 新进
Q1 2025 5.12M $11.22M 持有
Q2 2025 5.12M $9.99M 持有
Q3 2025 5.25M $8.50M 增持
Q4 2025 8.06M $16.53M 增持
Q1 2026 6.61M $11.10M 减持
Q2 2026 7.39M $15.00M 增持
Q3 2026 5.71M $11.73M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 IKT 与 13F 数据

IKT(INHIBIKASE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 66 只申报持有 IKT,申报仓位最大的包括:Sands Capital Alternatives, LLC (US$26.8M), Soleus Capital Management, L.P. (US$22.1M), Trails Edge Capital Partners, LP (US$18.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 IKT 的基金

查看 IKT 的全部基金持有人 →

常见问题

How long has ADAR1 Capital Management, LLC held IKT?

ADAR1 Capital Management, LLC has disclosed IKT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is ADAR1 Capital Management, LLC's current position in IKT?

As of Q3 2026, ADAR1 Capital Management, LLC holds 5.71M shares of IKT (INHIBIKASE THERAPEUTICS INC), valued at $11.73M, representing 0.64% of its reported portfolio and ranking #42.

Has ADAR1 Capital Management, LLC been buying or selling IKT?

In the latest 13F filing (Q3 2026), ADAR1 Capital Management, LLC reduced its position in IKT.

Which other funds hold IKT?

Other major institutional holders of IKT include Sands Capital Alternatives, LLC, Soleus Capital Management, L.P., Trails Edge Capital Partners, LP, among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.